|

Prospective Case Series Evaluating 6-Month and 12-Month Outcomes After Cryoneurolysis for Chronic Pain

RECRUITINGSponsored by Yale University
Actively Recruiting
SponsorYale University
Started2026-06-20
Est. completion2028-07
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site

Summary

To prospectively describe patient-centered and health utilization outcomes through 12 months after cryoneurolysis performed as routine clinical care for chronic pain at Yale.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Diagnosis of chronic pain (generally pain duration of at least 3-6 months) localized to an anatomical region appropriate for cryoneurolysis as determined by the treating physician.
* Planned cryoneurolysis procedure as part of standard clinical care.
* Ability to provide written informed consent.
* Ability and willingness to complete baseline and follow-up questionnaires.

Exclusion Criteria:

* Cryoneurolysis performed as part of a separate investigational trial in which data sharing is not permitted.
* Active infection or other clinical contraindication to the procedure as determined by the treating clinician.
* Life expectancy of less than 12 months in the judgment of the treating clinician.
* Any condition that, in the investigator's opinion, would interfere with study participation or completion of follow-up, such as severe psychiatric instability or active substance use that precludes reliable follow-up

Conditions15

ArthritisCausalgiaCervical SpondylosisChronic Hip PainChronic Low-back PainChronic Neck PainChronic PainChronic Pain SyndromeHip OsteoarthritisKnee Osteoarthritis

Locations1 site

Yale New Haven Health Old Saybrook Medical Center
Old Saybrook, Connecticut, 06475

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.